María Esther
Larrea Leoz
Catedrática de Universidad
Juan José
Lasarte Sagastibelza
Catedrático de Universidad
Publicaciones en las que colabora con Juan José Lasarte Sagastibelza (10)
2016
-
Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance
Journal of Medical Virology, Vol. 88, Núm. 5, pp. 843-851
2015
-
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
Molecular Therapy - Methods and Clinical Development, Vol. 2, pp. 15006
2013
-
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Journal of Hepatology, Vol. 59, Núm. 1, pp. 81-88
2011
-
Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection
Journal of Hepatology, Vol. 54, Núm. 3, pp. 422-431
-
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10
Hepatology, Vol. 53, Núm. 1, pp. 23-31
2007
-
Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer
Journal of Hepatology, Vol. 47, Núm. 6, pp. 807-815
-
Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection
Journal of Virology, Vol. 81, Núm. 7, pp. 3662-3666
-
Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity
Hepatology, Vol. 45, Núm. 3, pp. 602-613
2001
-
Dendritic cells infected with recombinant defective adenoviruses undergo NF-kB activation and partial maturation
INMUNOLOGÍA, Vol. 20, Núm. 3, pp. 130-142
1993
-
Enhancement of peptide immunogenicity by insertion of a cathepsin B cleavage site between determinants recognized by B and T cells
Research in Immunology, Vol. 144, Núm. 4, pp. 257-262